The PAI-1 4G/5G mutation did not increase the risk for the development of thrombosis, pregnancy morbidity or thrombocytopenia in our APS patients, which may be due to the genetic variation between races. This evidence concerns the gene SERPINE1 and deep vein thrombosis.